Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 29891000188112 | Mepolizumab | fr | Synonym (core metadata concept) | Inactive | Entire term case sensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 3304563013 | Mepolizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3304564019 | Mepolizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 749171000241110 | mépolizumab (substance) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 823821000172112 | mépolizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mepolizumab (substance) | est un(e) (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some | ||
| Mepolizumab (substance) | est un(e) (attribut) | Substance with interleukin 5 receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some | ||
| Mepolizumab (substance) | Has disposition (attribute) | Interleukin receptor antagonist (disposition) | false | Inferred relationship | Some | ||
| Mepolizumab (substance) | Has disposition (attribute) | Interleukin 5 receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing mepolizumab (medicinal product) | a pour principe actif (attribut) | True | Mepolizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only mepolizumab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Mepolizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only mepolizumab (medicinal product) | a pour principe actif (attribut) | True | Mepolizumab (substance) | Inferred relationship | Some | 1 |
| Mepolizumab-containing product in parenteral dose form | a pour principe actif (attribut) | True | Mepolizumab (substance) | Inferred relationship | Some | 1 |
| Mepolizumab 100 mg/mL solution for injection | Has precise active ingredient | True | Mepolizumab (substance) | Inferred relationship | Some | 1 |
| Mepolizumab 100 mg/mL solution for injection | Has basis of strength substance (attribute) | True | Mepolizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR